Skip to main content
Have a personal or library account? Click to login
Psychiatric Symptomatology and Medication Adherence in Type 2 Diabetes: Cross-Cultural Insights from Greece Cover

Psychiatric Symptomatology and Medication Adherence in Type 2 Diabetes: Cross-Cultural Insights from Greece

Open Access
|Aug 2026

References

  1. Ali, S. A., Salih, S. M., Abdelmola, A., Makeen, A. M., Solan, Y. M., Ali, M. M. M., ... Mahdi, M. (2024). Association of anxiety and depressive symptoms and treatment adherence among patients with type 2 diabetes mellitus in Jazan, Saudi Arabia: A cross-sectional study. Cureus, 16(3), e57021. https://doi.org/10.7759/cureus.57021
  2. Alotaibi, R. M., Alotaibi, A. S., Alotaibi, S. M., Al-Otaibi, M. S., Alharbi, A. F., & Almutairi, K. M. (2025). Effectiveness of nurse-led educational interventions on medication adherence among patients with diabetes: A systematic review. The Review of Diabetic Studies, 21(1), 747–757. https://doi.org/10.1900/RDS.2025.21.747
  3. Banday, M. Z., Sameer, A. S., & Nissar, S. (2020). Pathophysiology of diabetes: An overview. Avicenna Journal of Medicine, 10(4), 174–188. https://doi.org/10.4103/ajm.ajm_53_20
  4. Dai, E., Bakalis, V., Toska, A., Saridi, M., Papagiannis, D., Albani, E., Malli, F., & Fradelos, E. C. (2023). Assessment of depression and anxiety in patients with type 2 diabetes and their correlation with adherence to the Mediterranean diet and physical activity level. Hellenic Journal of Nursing, 62(4), 99–114.
  5. Derogatis, L. R. (1983). SCL-90-R: Administration, scoring and procedures manual II. Clinical Psychometric Research.
  6. DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160(14), 2101–2107. https://doi.org/10.1001/archinte.160.14.2101
  7. Donias, S., Karastergiou, A., & Manos, N. (1991). Standardization of the symptom checklist-90-R rating scale in a Greek population. Psychiatriki, 2, 42–48.
  8. Hao, L. N., Ma, X. W., Kang, L. N., Wang, Y. Y., & Shi, H. (2025). Beyond glycemic control: A holistic perspective on psychosocial support in outpatient diabetes management. Frontiers in Endocrinology, 16, 1708620. https://doi.org/10.3389/fendo.2025.1708620
  9. Hisan, U. K., Widjanarko, B., Sriatmi, A., & Shaluhiyah, Z. (2025). Association between depression and medication adherence in noncommunicable diseases: A narrative review. Korean Journal of Family Medicine, 46(4), 231–239. https://doi.org/10.4082/kjfm.25.0018
  10. Kalra, S., Jena, B. N., & Yeravdekar, R. (2018). Emotional and psychological needs of people with diabetes. Indian Journal of Endocrinology and Metabolism, 22(5), 696–704. https://doi.org/10.4103/ijem.IJEM_579_17
  11. Kardas, P., Bennett, B., Borah, B., Burnier, M., Daly, C., Hiligsmann, M., Menditto, E., Peterson, A. M., Slejko, J. F., Tóth, K., Unni, E., & Ágh, T. (2024). Medication non-adherence: Reflecting on two decades since WHO adherence report and setting goals for the next twenty years. Frontiers in Pharmacology, 15, 1444012. https://doi.org/10.3389/fphar.2024.1444012
  12. Kwakye, A. O., Kretchy, I. A., Peprah, P., & Mensah, K. B. (2024). Factors influencing medication adherence in co-morbid hypertension and diabetes patients: A scoping review. Exploratory Research in Clinical and Social Pharmacy, 13, 100426. https://doi.org/10.1016/j.rcsop.2024.100426
  13. Latkin, C. A., Edwards, C., Davey-Rothwell, M. A., & Tobin, K. E. (2017). The relationship between social desirability bias and self-reports of health, substance use, and social network factors among urban substance users in Baltimore, Maryland. Addictive Behaviors, 73, 133–136. https://doi.org/10.1016/j.addbeh.2017.05.005
  14. Liu, J. (2025). The impact of chronic diabetes on the mental health of middle-aged and elderly people: Mechanisms and intervention strategies. Theoretical and Natural Science, 141(1), 234–238. https://doi.org/10.54254/2753-8818/2025.AU27978
  15. Osborn, C. Y., & Egede, L. E. (2012). The relationship between depressive symptoms and medication nonadherence in type 2 diabetes: The role of social support. General Hospital Psychiatry, 34(3), 249–253. https://doi.org/10.1016/j.genhosppsych.2012.01.015
  16. Sahoo, J., Mohanty, S., Kundu, A., & Epari, V. (2022). Medication adherence among patients of type II diabetes mellitus and its associated risk factors: A cross-sectional study in a tertiary care hospital of Eastern India. Cureus, 14(12), e33074. https://doi.org/10.7759/cureus.33074
  17. Sebastian, M. J., Khan, S. K., Pappachan, J. M., & Jeeyavudeen, M. S. (2023). Diabetes and cognitive function: An evidence-based current perspective. World Journal of Diabetes, 14(2), 92–109. https://doi.org/10.4239/wjd.v14.i2.92
  18. Seghatoleslam, T., Ardakani, A., Habil, H., & Rashid, R. (2022). Comorbidity of mental disorder in patients with chronic disease: A comparative study of heroin dependence patients and diabetes mellitus patients. Iranian Journal of Public Health, 51(1), 142–150. https://doi.org/10.18502/ijph.v51i1.8305
  19. Shukla, M., Schilt-Solberg, M., & Gibson-Scipio, W. (2025). Medical mistrust: A concept analysis. Nursing Reports (Pavia, Italy), 15(3), 103. https://doi.org/10.3390/nursrep15030103
  20. Stewart, S. J. F., Moon, Z., & Horne, R. (2023). Medication nonadherence: Health impact, prevalence, correlates and interventions. Psychology & Health, 38(6), 726–765. https://doi.org/10.1080/08870446.2022.2144923
  21. Unni, E. J., & Farris, K. B. (2015). Development of a new scale to measure self-reported medication nonadherence. Research in Social & Administrative Pharmacy: RSAP, 11(3), e133–e143. https://doi.org/10.1016/j.sapharm.2009.06.005
  22. Unni, E. J., Olson, J. L., & Farris, K. B. (2014). Revision and validation of Medication Adherence Reasons Scale (MAR-Scale). Current Medical Research and Opinion, 30(2), 211–221. https://doi.org/10.1185/03007995.2013.851075
  23. Unni, E. J., Sternbach, N., & Goren, A. (2019). Using the Medication Adherence Reasons Scale (MAR-Scale) to identify the reasons for non-adherence across multiple disease conditions. Patient Preference and Adherence, 13, 993–1004. https://doi.org/10.2147/PPA.S205359
  24. Xu, H., & Chen, Q. (2025). The bidirectional influence between type 2 diabetes mellitus and the state of depression and anxiety. Journal of Affective Disorders, 386, 119467. https://doi.org/10.1016/j.jad.2025.119467
  25. Yang, H., Wu, F., Gui, M., et al. (2023). The role of medication adherence in the association between depressive symptoms and quality of life in older adults with type 2 diabetes mellitus. BMC Geriatrics, 23, 196. https://doi.org/10.1186/s12877-023-03929-8
  26. Yang, K., Fang, Y., He, J., & Li, J. (2025). Prevalence and risk factors of depression in patients with diabetes mellitus: A systematic review and meta-analysis. Frontiers in Endocrinology, 16, 1660478. https://doi.org/10.3389/fendo.2025.1660478
  27. Zolnierek, K. B., & DiMatteo, M. R. (2009). Physician communication and patient adherence to treatment: A meta-analysis. Medical Care, 47(8), 826–834. https://doi.org/10.1097/MLR.0b013e31819a5acc
Language: English
Page range: 155 - 178
Submitted on: May 24, 2026
Accepted on: Aug 1, 2026
Published on: Aug 5, 2026
Published by: International Platform on Mental Health
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open

© 2026 Evangelos C. Fradelos, Maria Faka, Dimitra Anagnostopoulou, Vissarion Bakalis, Elizabeth Uni, Aikaterini Toska, Konstantinos Skabardonis, Victoria Alikari, Maria Saridi, published by International Platform on Mental Health
This work is licensed under the Creative Commons Attribution 4.0 License.